Active ingredientDoxazosinCat. No. P-D180-001CAS 74191-85-8Family · Pharmaceutical analytical standards
Doxazosin
An alpha-1 blocker of the quinazoline family, patented in 1977 and in use since 1988 for benign prostatic hyperplasia and high blood pressure: it relaxes blood vessels and the muscle of the prostate. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Compared with prazosin, its older relative, it lasts much longer in the body: one dose a day is enough, against up to four for its predecessor.
Go to the active ingredient →Active ingredientDoxazosinCat. No. P-D180-001CAS 74191-85-8
Active ingredientDoxazosin MesilateCat. No. P-D180-002CAS 77883-43-3
Pharmacopoeial impurityDoxazosin EP Impurity DCat. No. P-D180-003CAS 28888-44-0
Pharmacopoeial impurityDoxazosin EP Impurity ECat. No. P-D180-004CAS 27631-29-4
Pharmacopoeial impurityDoxazosin EP Impurity FCat. No. P-D180-005CAS 23680-84-4
Pharmacopoeial impurityDoxazosin EP Impurity H HClCat. No. P-D180-006CAS 2970483-26-0
Pharmacopoeial impurityDoxazosin Mesilate EP Impurity ACat. No. P-D180-007CAS 3663-80-7
Pharmacopoeial impurityDoxazosin Mesilate EP Impurity B HClCat. No. P-D180-008CAS 70918-74-0
Pharmacopoeial impurityDoxazosin Mesilate EP Impurity CCat. No. P-D180-009CAS 617677-53-9
Isotopically labelledDoxazosin-d8Cat. No. P-D180-010CAS 1126848-44-9
Isotopically labelledDoxazosin-d8 HClCat. No. P-D180-011CAS 1219803-95-8
Isotopically labelledR-Doxazosin-d8Cat. No. P-D180-012
Isotopically labelledS-Doxazosin-d8Cat. No. P-D180-013
NitrosamineN-Nitroso Doxazosin EP Impurity BCat. No. P-D180-014
Pharmacopoeial impurityDoxazosin EP Impurity F MesilateCat. No. P-D180-015CAS 2727065-71-4
Impurity7'-Hydroxy DoxazosinCat. No. P-D180-016CAS 102932-28-5
ImpurityDoxazosin Impurity 2Cat. No. P-D180-017
ImpurityDoxazosin Impurity 3Cat. No. P-D180-018CAS 102932-26-3
ImpurityDoxazosin Impurity 4Cat. No. P-D180-019
ImpurityDoxazosin Impurity 5Cat. No. P-D180-020
Pharmacopoeial impurityDoxazosin USP Related Compound GCat. No. P-D180-022CAS 664347-52-8
Pharmacopoeial impurityDoxazosin USP Related Compound G HClCat. No. P-D180-023CAS 134749-43-2
ImpurityDoxazosin Impurity 6Cat. No. P-D180-024CAS 4739-94-0
ImpurityMethyl 1,4-Benzodioxan-2-carboxylateCat. No. P-D180-025CAS 3663-79-4
ImpurityR-DoxazosinCat. No. P-D180-026CAS 70918-17-1
ImpurityS-DoxazosinCat. No. P-D180-027CAS 104874-86-4No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
ImpurityDoxazosin impurity D CRSEDQM code Y0000551Family DoxazosinImpurityDoxazosin impurity F CRSEDQM code Y0000552Family DoxazosinReference substanceDoxazosin mesilate CRSEDQM code Y0000553Family DoxazosinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.